Ad
related to: intas pharmaceuticals jobsjobs2careers.com has been visited by 100K+ users in the past month
Major US Companies Are Hiring Now and Increasing Pay. All Current Jobs Hiring Near You. Newly Posted Jobs Near Me. No Experience Required. Find Your Dream Job Near You Today!
Search results
Jul 4, 2024 · 1 Intas Pharmaceuticals Assistant General Manager IT Mumbai Review about salary & benefits work culture skill development career growth job security work-life balance and more. Read more about working at Intas Pharmaceuticals.
Jul 13, 2024 · This came after Intas Pharmaceuticals presented their proposal for a grant of permission to conduct the palatability study (acceptability, taste & smell, and oro-mucosal safety) for Temozolomide powder for oral suspension at 20 mg/ml (300 mg/15 ml) in pediatric patients with malignant gliomas, along with the palatability study protocol, before the committee.
Jun 29, 2024 · The financial reports of INTAS PHARMACEUTICALS LIMITED include financial history (previous 5 Years), ratio analysis, management details such as directors & key persons of the company, shareholding & group structure details, mortgages & charges on INTAS PHARMACEUTICALS LIMITED.
Jun 29, 2024 · The last reported AGM (Annual General Meeting) of Intas Pharmaceuticals Limited, per our records, was held on 31 July, 2023. Intas Pharmaceuticals Limited has 11 directors - Urmish Hasmukh Chudgar, Binish Hasmukh Chudgar, and others. The Corporate Identification Number (CIN) of Intas Pharmaceuticals Limited is U24231GJ1985PLC007866.
Jul 19, 2024 · As an early entrant in the Credit Rating business, ICRA Limited (ICRA) is one of the most experienced Credit Rating Agencies in the country today.ICRA rates rupee-denominated debt instruments issued by manufacturing companies, commercial banks, non-banking finance companies, financial institutions, public sector undertakings and municipalities, among others.
Jul 19, 2024 · What is Intas Pharmaceuticals Limited? Hasmukh Chudgar, a Jain pharmacist, founded the business in 1977, and it was incorporated in 1985. In 2013, ChrysCapital bought a 16.14% stake in the business; in 2015, it sold 10.13% of that stake to Temasek Holdings in Singapore; and in 2017, it further diluted its stake by selling 3.01% of it to Capital International.
